<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2795-5001</journal-id>
<journal-title><![CDATA[Portuguese Journal of Dermatology and Venereology]]></journal-title>
<abbrev-journal-title><![CDATA[Port J Dermatol Venereol.]]></abbrev-journal-title>
<issn>2795-5001</issn>
<publisher>
<publisher-name><![CDATA[Permanyer Publications]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2795-50012025000200101</article-id>
<article-id pub-id-type="doi">10.24875/pjdv.24000104</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Wound management and dressing selection in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review]]></article-title>
<article-title xml:lang="pt"><![CDATA[Manejo de feridas e seleção de curativos na síndrome de Stevens-Johnson e necrólise epidérmica tóxica: uma revisão sistemática]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Macagnan]]></surname>
<given-names><![CDATA[Maiara C.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Francisco]]></surname>
<given-names><![CDATA[Priscila de Cassia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Kliemann]]></surname>
<given-names><![CDATA[Breno S.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mehl]]></surname>
<given-names><![CDATA[Adriano A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Santa Casa de Misericórdia de Curitiba Department of Dermatology ]]></institution>
<addr-line><![CDATA[Paraná ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>83</volume>
<numero>2</numero>
<fpage>101</fpage>
<lpage>112</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2795-50012025000200101&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2795-50012025000200101&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2795-50012025000200101&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objectives: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse drug reactions, which lead to epidermal detachment and may be life-threatening. Apart from supportive and systemic treatment of the disease, appropriate dressing and wound management are essential for the care of patients with SJS/TEN. This study aims to assess which are the most used dressings for SJS/TEN, and how wound management can contribute to skin healing.  Methods: Searches were performed in Cochrane Library, Embase, MEDLINE, and PubMed databases, using the following search terms: (SJS OR TEN) AND (Wounds OR Dressings). Information extracted on dressings was used as well as local care (including materials for cleansing, debridement, topical therapy, fixation, and time for dressing changing) and time for re-epithelialization.  Results: A total of 17 articles published in the last 11 years were selected. Six (35.3%) mentioned silver-based topical therapies as treatment of choice. Allografts and porcine xenografts were cited by a further 6 (35.3%) studies, biosynthetic dressings with a combination of collagen mesh and silicone by 4 (23.5%), petrolatum-based products by 4 (23.5%), and patient&#8217;s own detached skin as a biological dressing by 2 (11.8%) studies.  Conclusion: Upon analysis of collected data, it was noted that little information is available on topical treatment in SJS and TEN, with no consensus on an ideal protocol for such cases. Therefore, dressing management for these disorders remains a challenge in care, and further research on this subject should be encouraged.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivos: A síndrome de Stevens-Johnson (SSJ) e a necrólise epidérmica tóxica (NET) são reações adversas cutâneas graves a medicamentos, que levam ao descolamento epidérmico e podem ser fatais. Além do tratamento de base, os cuidados locais e a seleção dos tratamentos tópicos/pensos são essenciais para o cuidado de pacientes com SSJ/NET. E objetivo e avaliar os diferentes cuidados locais e tipos de pensos mais utilizados na SSJ/NET e o seu contributo para a reepitelização nessas doenças.  Métodos: Foram realizadas pesquisas nas bases de dados Cochrane Library, Embase, MEDLINE e PubMed, usando os seguintes termos de busca: (SJS OR TEN) AND (Wounds OR Dressings). Foram extraídas informações sobre os pensos utilizados bem como os cuidados locais (materiais usados para limpeza, desbridamento, terapia tópica, fixação e tempo para troca de curativo) e sua relação com a reepitelização.  Resultados: Foram selecionados 17 artigos publicados nos últimos 11 anos. Seis (35.3%) estudos mencionaram terapias tópicas à base de pensos impregnados de prata como tratamento de escolha. Aloenxertos e xenoenxertos porcinos foram citados em 6 (35.3%) estudos, curativos biossintéticos com combinação de malha de colágeno e silicone foram citados por 4 (23.5%), produtos à base de vaselina por 4 (23.5%), e a própria pele destacada como curativo biológico por 2 (11.8%) estudos.  Conclusão: Após a análise dos dados coletados, verificou-se que há pouca informação disponível sobre o tratamento tópico em SSJ e NET, não havendo consenso sobre um protocolo ideal para tais casos. Portanto, os cuidados locais continuam um desafio, devendo ser encorajadas mais pesquisas sobre esse assunto.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Wounds]]></kwd>
<kwd lng="en"><![CDATA[Stevens-Johnson syndrome]]></kwd>
<kwd lng="en"><![CDATA[Toxic epidermal necrolysis]]></kwd>
<kwd lng="en"><![CDATA[Dressings]]></kwd>
<kwd lng="pt"><![CDATA[Feridas]]></kwd>
<kwd lng="pt"><![CDATA[Síndrome de Stevens-Johnson]]></kwd>
<kwd lng="pt"><![CDATA[Necrólise epidérmica tóxica]]></kwd>
<kwd lng="pt"><![CDATA[Curativos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Charlton]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Phan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mewton]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxic epidermal necrolysis and Steven-Johnson syndrome:a comprehensive review]]></article-title>
<source><![CDATA[Adv Wound Care]]></source>
<year>2020</year>
<volume>9</volume>
<page-range>426-39</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naik]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Scars Burn Heal]]></source>
<year>2022</year>
<volume>8</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Panwar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pande]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Arora]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug-related Stevens-Johnson syndrome and toxic epidermal necrolysis:a review]]></article-title>
<source><![CDATA[Indian J Crit Med]]></source>
<year>2021</year>
<volume>25</volume>
<page-range>575-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Vera]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega-Loayza]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Seminario-Vidal]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis]]></article-title>
<source><![CDATA[J Am Acad Dermatol]]></source>
<year>2018</year>
<volume>79</volume>
<page-range>764-7.e1</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frantz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Are]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Motaparthi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stevens-Johnson syndrome and toxic epidermal necrolysis:a review of diagnosis and management]]></article-title>
<source><![CDATA[Medicina (Kaunas)]]></source>
<year>2021</year>
<volume>57</volume>
<page-range>895</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<collab>Joanna Briggs Institute (JBI)</collab>
<article-title xml:lang=""><![CDATA[Critical Appraisal Tools]]></article-title>
<source><![CDATA[JBI]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<collab>National Institute for Health Research (NIHR)</collab>
<article-title xml:lang=""><![CDATA[PROSPERO]]></article-title>
<source><![CDATA[National Institute for Health Research]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Page]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[McKenzie]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Boutron]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Mulrow]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The PRISMA 2020 statement:an updated guideline for reporting systematic reviews]]></article-title>
<source><![CDATA[Br Med J]]></source>
<year>2021</year>
<volume>372</volume>
<page-range>n71</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahar]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
<name>
<surname><![CDATA[Wasiak]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hii]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cleland]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Watters]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Gin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres]]></article-title>
<source><![CDATA[Burns]]></source>
<year>2014</year>
<volume>40</volume>
<page-range>1245-54</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[KP]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical evaluation comparing the efficacy of Aquacel Ag with vaseline gauze versus 1% silver sulfadiazine cream in toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Adv Skin Wound Care]]></source>
<year>2014</year>
<volume>27</volume>
<page-range>210-5</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Gondek]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Troche]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Summitt]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Rae]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Thayer]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of porcine xenografts in patients with toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Burns]]></source>
<year>2016</year>
<volume>42</volume>
<page-range>1728-33</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Blackport]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cartotto]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of Biobrane® for wound coverage in Stevens-Johnson syndrome and toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Burns]]></source>
<year>2017</year>
<volume>43</volume>
<page-range>1464-72</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paggiaro]]></surname>
<given-names><![CDATA[AO]]></given-names>
</name>
<name>
<surname><![CDATA[Silva Filho]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[de Carvalho]]></surname>
<given-names><![CDATA[VF]]></given-names>
</name>
<name>
<surname><![CDATA[Isaac]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gemperli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of biological skin substitutes in Stevens-Johnson syndrome:systematic review]]></article-title>
<source><![CDATA[Plast Surg Nurs]]></source>
<year>2018</year>
<volume>38</volume>
<page-range>121-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richard]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
<name>
<surname><![CDATA[Hamer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Musso]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Short]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[O'Neal Jr]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Variability in management of patients With SJS/TEN:a survey of burn unit directors]]></article-title>
<source><![CDATA[J Burn Care Res]]></source>
<year>2018</year>
<volume>39</volume>
<page-range>585-92</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Mallitt]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Saunderson]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An individual patient data meta-analysis of wound care in patients with toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Australas J Dermatol]]></source>
<year>2024</year>
<volume>65</volume>
<page-range>128-42</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Creamer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Dziewulski]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Exton]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Dart]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016 (print summary - Full guidelines available at http://dx.doi.org/10.1016/j.bjps.2016.01.034)]]></article-title>
<source><![CDATA[J Plast Reconstr Aesthet Surg]]></source>
<year>2016</year>
<volume>69</volume>
<page-range>736-41</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[McDonough]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxic epidermal necrolysis]]></article-title>
<source><![CDATA[J Am Acad Dermatol]]></source>
<year>2013</year>
<volume>69</volume>
<page-range>187.e1-16</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dodiuk-Gad]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Olteanu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jeschke]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Cartotto]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fish]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shear]]></surname>
<given-names><![CDATA[NH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of toxic epidermal necrolysis in North America]]></article-title>
<source><![CDATA[J Am Acad Dermatol]]></source>
<year>2015</year>
<volume>73</volume>
<page-range>876-77.e2</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wolkenstein]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[YT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxic epidermal necrolysis:the past, the guidelines and challenges for the future]]></article-title>
<source><![CDATA[J Plast Reconstr Aesthet Surg]]></source>
<year>2016</year>
<volume>69</volume>
<page-range>733-5</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cartotto]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Burn center care of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Clin Plast Surg]]></source>
<year>2017</year>
<volume>44</volume>
<page-range>583-95</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dastagir]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kijas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Obed]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Tamulevicius]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vogt]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Dastagir]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Suprathel® and water-filtered infrared-A radiation (wIRA) as a new treatment strategy for toxic epidermal necrolysis (TEN):a prospective study]]></article-title>
<source><![CDATA[Burns]]></source>
<year>2024</year>
<volume>50</volume>
<page-range>107283</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Enescu]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Elder]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Deirawan]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Moossavi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[To debride or not to debride:a review of wound management for Stevens-Johnson syndrome and toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2024</year>
<volume>16</volume>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jaller]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[McLellan]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Balagula]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Wound management in Stevens-Johnson syndrome and toxic epidermal necrolysis]]></article-title>
<source><![CDATA[Curr Dermatol Rep]]></source>
<year>2020</year>
<volume>9</volume>
<page-range>58-72</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curtis]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Christensen]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Paine]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Brummer]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Summers]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Cochran]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stevens-Johnson syndrome and toxic epidermal necrolysis treatments:an Internet survey]]></article-title>
<source><![CDATA[J Am Acad Dermatol]]></source>
<year>2016</year>
<volume>74</volume>
<page-range>379-80</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
